Evaluation of medicinal products for cardiovascular disease prevention - Scientific guideline

HumanScientific guidelines

Slovenian is available via eTranslation, the European Commission's machine translation service.

Translate to Slovenian | Important information about machine translation

This document provides guidance for the clinical evaluation of drugs in the prevention of cardiovascular events.

Keywords: Cardiovascular prevention, risk scoring models, SCORE system, Framingham risk score

Current effective version

Guideline on the evaluation of medicinal products for cardiovascular disease prevention

Adopted Reference Number: EMEA/CHMP/EWP/311890/2007 Legal effective date:

English (EN) (112.36 KB - PDF)

Prva objava: Zadnja posodobitev:
Prikaži

Document history

Overview of comments received on draft guideline on the evaluation of medicinal products for cardiovascular disease prevention (EMEA/CHMP/EWP/311890/2007)

Reference Number: EMEA/CHMP/EWP/357298/2008

English (EN) (105.13 KB - PDF)

Prva objava: Zadnja posodobitev:
Prikaži

Draft guideline on the evaluation of medicinal products for cardiovascular disease prevention

Draft: consultation closed Reference Number: EMEA/CHMP/EWP/311890/2007

English (EN) (50.29 KB - PDF)

Prva objava: Zadnja posodobitev:
Prikaži

Concept paper on the development of a committee for medicinal products for human use (CHMP) note for guidance on the need for regulatory guidance in the evaluation of medicinal products for the secondary cardiovascular p...

Reference Number: CHMP/EWP/1470/04

English (EN) (134.84 KB - PDF)

Prva objava: Zadnja posodobitev:
Prikaži

Share this page